Matija Peterlin

Matija Peterlin is a Professor at the University of California San Francisco, renowned for his contributions to HIV research, molecular biology, and transcription regulation. His work focuses on mechanisms of HIV transactivation, latency, and viral protein functions, particularly Nef and TAT.

• Education: Duke University (B.S. in Chemistry, 1968) and Harvard Medical School (M.D., 1973)

Peterlin's research explores the role of P-TEFb in transcription elongation, HIV latency reversal, and the function of viral proteins in immune evasion. His recent work involves kinase pathways, exosome-mediated protein secretion, and noncoding RNA regulation.

His 15 most recent articles (2021–1990) cover topics such as HIV protein Nef, TAT transactivation, 7SK snRNA, and pharmacological strategies for HIV eradication. These publications highlight expertise in molecular virology, gene regulation, and immunology.

Scientific honors include the Alexander von Humboldt Prize (1998–present), Rosalind Russell Scholar (1995–present), and early career fellowships from the Leukemia Society and American Cancer Society.

As Principal or Co-Investigator on 10 NIH-funded grants (1977–2022), Peterlin has advanced understanding of HIV transcription, latency, and accessory protein functions. His work has significant implications for antiretroviral therapy and gene expression studies.